Recently, aberrant expression of SNHG17 has been suggested to play vital roles in the development and progression of human carcinomas, such as gastric cancer, prostate cancer, non-small cell lung cancer (NSCLC), and breast cancer, etc [11–14]. This evidence concerns the gene SNHG17 and non-small cell lung carcinoma.